top of page
Investor Material
Top
Webcasts / Presentations
Videos
Corporate Publications
Webcast
WEBCASTS / PRESENTATIONS
Phase IIb/III Trial of Blarcamesine in Early Alzheimer Disease Demonstrates Pre-specified Clinical Efficacy Through Upstream SIGMAR1 Activation
Anavex Presents at the 19th NFXF International Fragile X Conference, July 30
Anavex Life Sciences Fiscal 2024 Q3 Earnings Call
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
Clinical Trials on Alzheimer’s Disease (CTAD) Medical Conference - LATE BREAKING COMMUNICATIONS
Anavex Life Sciences Presented at Alzheimer's Association Conference, July 28
H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference, June 27
H.C. Wainwright 2nd Annual BioConnect Investor Conference, May 20
Anavex Life Sciences Presents at the Noble Capital Markets Virtual Healthcare Equity Conference
Anavex Life Sciences Presents at the 23rd Annual Needham Virtual Healthcare Conference
Anavex Life Sciences Presents at TD Cowen 44th Annual Health Care Conference
Video
VIDEOS
Educational Video News Release: Broad SIGMAR1 Platform June 2022
Rett Syndrome Association of Australia - Videos
Corporate Publications
CORPORATE PRESENTATIONS
Corporate Presentation September 2024
Stay Connected
Follow us on social media
Events
Newsroom
Contact Us
bottom of page
